GCS Resources - Page 2 of 4 - The GCS Project

Scientific Resources – Intro

Here are some articles on uterine carcinosarcoma:   NCCN Guidelines: Uterine Neoplasms, 2017   Uterine Carcinosarcoma, Review of the literature, 2015 – the latest comprehensive review   Arend, Endometrial cancer: Molecular markers and management of advanced stage disease – the article doe not discuss carcinosarcoma, but it addresses the subject of molecular markers.


Posted: November 13, 2017 | View More »


Knowledge truly is power – and part of our mission is to provide the correct information about gynecologic carcinosarcoma (GCS), also known as malignant mixed Müllerian tumor (MMMT).   Visit our “WHAT IS GCS / MMMT?” page to read more details about this type of cancer and it’s treatment options. Click Here   Message from Diane: […]


Posted: November 13, 2017 | View More »


Clinical Trials

 We see some clinical trials in the future: The major research being performed at the Broad Institute (Broad Institute Link – Click Here) in Boston is scheduled to be completed in the next 8-12 weeks. Once the data is collected, data analysis will take another 4-6 weeks. The analysis of the data will yield potential targets for […]


Posted: October 2, 2017 | View More »


IMPORTANT GCS TREATMENT UPDATE

Hello everyone – There is important and new GCS treatment information posted on our Forum. Please click this link and share comments there!


Posted: September 14, 2017 | View More »


Dr. Birrer will stay involved with the GCS Project

Bittersweet News Dr. Birrer is moving from Mass General Cancer Center to become the head of the Comprehensive Cancer Center at the University of Alabama in Birmingham (UAB) as of August 1, 2017. Dr. Birrer remains dedicated to the GCS Project and will launch a GCS Clinic devoted to helping women with gynecological carcinosarcoma obtain […]


Posted: August 8, 2017 | View More »


The GCS Project is a 501c3 Organization

(updated 1/27/18) The GCS Project has received approval from the IRS to become a 501(c)(3)!    Why is it important for The GCS Project to become a 501c3?    Obtaining 501c3 status enables the GCS Project to become eligible for grants and other public and private allocations available only to IRS-recognized,501(c)(3) organizations. In addition, when and organization has obtained […]


Posted: August 8, 2017 | View More »


Thank You Kevin! $5500 Raised for GCS

  On May 7th, Kevin Schieferstein ran the Pittsburgh Marathon to raise money for the GCS Project. He raised $5500! Kevin, we cannot thank you enough for your support. What an amazing run!  


Posted: May 11, 2017 | View More »


Second Opinions for GYN Carcinosarcoma (MMMT) with Dr. Marcela del Carmen (Part 9) [VIDEO]

Patient/advocate Diane Redington and Dr. Marcela del Carmen discuss the importance of being armed with as much information as possible in fighting gynecological carcinosarcoma. This is the ninth video of our nine-part series.   Dr. Marcela del Carmen explains that patients live longer when being treated by doctors that are true experts in GYN carcinosarcoma […]


Posted: May 9, 2017 | View More »


Advocacy with GYN Carcinosarcoma (MMMT) with Dr. Marcela del Carmen (Part 8) [VIDEO]

Patient/advocate Diane Redington and Dr. Marcela del Carmen discuss the importance of clinical trials and the extreme lack of funding for gynecological cancer research. This is part eight of a nine-part series. Dr. Marcela del Carmen explains that the field is on the forefront of major discoveries in understanding the biology of this carcinosarcoma; however, […]


Posted: May 7, 2017 | View More »


Diagnosis and Treatment with Dr. Marcela del Carmen (Part 7) [VIDEO]

Patient/advocate Diane Redington and Dr. Marcela del Carmen discuss diagnosis and treatment of gynecological carcinosarcoma (MMMT). This is part seven of a nine-part series. Dr. Marcela del Carmen discusses how gynecological carcinosarcoma is different than ovarian or uterine cancers. It is very important to get an accurate diagnosis from an expert to confirm exactly what […]


Posted: May 5, 2017 | View More »